Gabriella Gobbi
Gabriella Gobbi
Professor, McGill University, Montreal, Canada
Verified email at mcgill.ca - Homepage
TitleCited byYear
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi, FR Bambico, R Mangieri, M Bortolato, P Campolongo, M Solinas, ...
Proceedings of the National Academy of Sciences 102 (51), 18620-18625, 2005
6082005
Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function
L Santarelli, G Gobbi, PC Debs, EL Sibille, P Blier, R Hen, MJS Heath
Proceedings of the National Academy of Sciences 98 (4), 1912-1917, 2001
3402001
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype
C Heurteaux, G Lucas, N Guy, M El Yacoubi, S Thümmler, XD Peng, ...
Nature neuroscience 9 (9), 1134, 2006
3272006
Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex
FR Bambico, N Katz, G Debonnel, G Gobbi
Journal of Neuroscience 27 (43), 11700-11711, 2007
2632007
Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study
G Gobbi, DL Murphy, KP Lesch, P Blier
Journal of Pharmacology and Experimental Therapeutics 296 (3), 987-995, 2001
1662001
Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation
P Blier, G Gobbi, JE Turcotte, C de Montigny, N Boucher, C Hébert, ...
European Neuropsychopharmacology 19 (7), 457-465, 2009
1412009
Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission
FR Bambico, NT Nguyen, N Katz, G Gobbi
Neurobiology of disease 37 (3), 641-655, 2010
1282010
The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants
MN Hill, CJ Hillard, FR Bambico, S Patel, BB Gorzalka, G Gobbi
Trends in Pharmacological Sciences 30 (9), 484-493, 2009
1232009
Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design
J Mazella, O Pétrault, G Lucas, E Deval, S Béraud-Dufour, C Gandin, ...
PLoS biology 8 (4), e1000355, 2010
1212010
Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response
P Blier, G Gobbi, N Haddjeri, L Santarelli, G Mathew, R Hen
Journal of Psychiatry and Neuroscience 29 (3), 208, 2004
1112004
Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress
FR Bambico, NT Nguyen, G Gobbi
European Neuropsychopharmacology 19 (3), 215-228, 2009
1092009
CCNP Award Paper: Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology
S Comai, G Gobbi
Journal of psychiatry & neuroscience: JPN 39 (1), 6, 2014
942014
Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain
B Lacoste, D Angeloni, S Dominguez‐Lopez, S Calderoni, A Mauro, ...
Journal of Pineal Research 58 (4), 397-417, 2015
932015
Endocannabinoids in the treatment of mood disorders: evidence from animal models
F Rodriguez Bambico, A Duranti, A Tontini, G Tarzia, G Gobbi
Current pharmaceutical design 15 (14), 1623-1646, 2009
892009
The Psychopharmacology of Aggressive Behavior: A Translational ApproachPart 1 Neurobiology
S Comai, M Tau, G Gobbi
Journal of clinical psychopharmacology 32 (1), 83-94, 2012
882012
The Psychopharmacology of Aggressive Behavior: A Translational ApproachPart 2 Clinical Studies Using Atypical Antipsychotics, Anticonvulsants, and Lithium
S Comai, M Tau, Z Pavlovic, G Gobbi
Journal of clinical psychopharmacology 32 (2), 237-260, 2012
862012
Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation
AC Jansen, O Sancak, MD D'Agostino, A Badhwar, P Roberts, G Gobbi, ...
Annals of Neurology: Official Journal of the American Neurological …, 2006
852006
Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus
FR Bambico, T Cassano, S Dominguez-Lopez, N Katz, CD Walker, ...
Neuropsychopharmacology 35 (10), 2083, 2010
842010
Cannabinoids and emotionality: a neuroanatomical perspective
RJ McLaughlin, G Gobbi
Neuroscience 204, 134-144, 2012
742012
Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway
RJ McLaughlin, MN Hill, FR Bambico, KL Stuhr, G Gobbi, CJ Hillard, ...
European Neuropsychopharmacology 22 (9), 664-671, 2012
722012
The system can't perform the operation now. Try again later.
Articles 1–20